A point‐based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: Our objective in this study was to develop a point‐based tool to predict conversion from amnestic mild cognitive impairment (MCI) to probable Alzheimer's disease (AD). Methods: Subjects were participants in the first part of the Alzheimer's Disease Neuroimaging Initiative. Cox proportional hazards models were used to identify factors associated with development of AD, and a point score was created from predictors in the final model. Results: The final point score could range from 0 to 9 (mean 4.8) and included: the Functional Assessment Questionnaire (2‒3 points); magnetic resonance imaging (MRI) middle temporal cortical thinning (1 point); MRI hippocampal subcortical volume (1 point); Alzheimer's Disease Cognitive Scale—cognitive subscale (2‒3 points); and the Clock Test (1 point). Prognostic accuracy was good (Harrell's c = 0.78; 95% CI 0.75, 0.81); 3‐year conversion rates were 6% (0‒3 points), 53% (4‒6 points), and 91% (7‒9 points). Conclusions: A point‐based risk score combining functional dependence, cerebral MRI measures, and neuropsychological test scores provided good accuracy for prediction of conversion from amnestic MCI to AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Self-citationMild Cognitive Impairment: Ten Years Later
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.266 · Cited by 1,447
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
A general cardiovascular risk profile: The Framingham study
Kannel, W. B., McGee, D., & Gordon, T. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90061-8 · Cited by 1,189
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833
Development and Validation of a Prognostic Index for 4-Year Mortality in Older Adults
Lee, S. J. (2006) · JAMA · doi:10.1001/jama.295.7.801 · Cited by 809 · cited 1×
“This method for determining points has been used successfully in the development of other clinical prediction tools [17,19].”
MethodSelf-citationComparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e8b8 · Cited by 616
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007) · Brain · doi:10.1093/brain/awm112 · Cited by 607 · cited 1×
“These have primarily included markers of amyloid-b (Ab) deposition, such as Pittsburgh compound B (PiB) positron emission tomography (PET) [9,10] and cerebrospinal fluid (CSF) Ab levels [11], and markers of neuronal injury, such as CSF total and phosphorylated tau [11], fluorodeoxyglucose (FDG) PET [12,13], and struct…”
BackgroundBaseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort
Risacher, S., Saykin, A., Wes, J., Shen, L., Firpi, H., & McDonald, B. (2009) · Current Alzheimer Research · doi:10.2174/156720509788929273 · Cited by 538 · cited 1×
“These have primarily included markers of amyloid-b (Ab) deposition, such as Pittsburgh compound B (PiB) positron emission tomography (PET) [9,10] and cerebrospinal fluid (CSF) Ab levels [11], and markers of neuronal injury, such as CSF total and phosphorylated tau [11], fluorodeoxyglucose (FDG) PET [12,13], and struct…”
Background
Cited by
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.11.007 · Cited by 315
Self-citationLi, H., Habes, M., Wolk, D. A., Fan, Y., & Aging, A. D. N. I. A. T. A. I. B. A. L. S. O. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.02.007 · Cited by 264
Lombardi, G., Crescioli, G., Cavedo, E., Lucenteforte, E., Casazza, G., Bellatorre, A.-G., Lista, C., Costantino, G., Frisoni, G., Virgili, G., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009628.pub2 · Cited by 214
Prediction of Conversion to Alzheimer’s Disease with Longitudinal Measures and Time-To-Event Data
Li, K., Chan, W., Doody, R. S., Quinn, J., Luo, S., & Initiative, T. A. D. N. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161201 · Cited by 126
“Most existingstudies[12,13]ofpredictingtime-to-AD adopt Cox regression models with baseline measures.”
Li, K., O'Brien, R., Lutz, M., Luo, S., & Initiative, T. A. D. N. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.11.004 · Cited by 44
Metadata
- Authors
- Barnes, D. E., Cenzer, I. S., Yaffe, K., Ritchie, C. S., Lee, S. J., & Initiative, A. D. N.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2014-02-03
- Volume
- 10
- Issue
- 6
- Pages
- 646-655
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2064913229
- Cited by
- 55
- References
- 11
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A point‐based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.jalz.2013.12.014
- The paper
- Barnes, D. E., Cenzer, I. S., Yaffe, K., Ritchie, C. S., Lee, S. J., & Initiative, A. D. N. (2014). A point‐based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2013.12.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.